Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Digiday+ Research: Half of marketers say ad spend will grow this year
Marketers have big expectations for ad spend this year — just short of half of marketer pros said they agree advertisers will spend more in 2025.
Will a ‘rebrand’ of the CMO create a better balance between brand and performance marketing?
The hope is that the variation of marketing organization makeup will allow marketers — CMOs or whatever the title may be — to continue to swing the pendulum back to brand.
Fragmentation comes to search advertising as marketers grapple with shifting search behavior
Search ads are changing. Here’s how marketers are preparing for a new search landscape.